Advertisement
MINNEAPOLIS and ST. PAUL, Minn., May 22 /PRNewswire/ Children's Hospitalsand Clinics of Minnesota has published its inaugural Care Innovation andResearch Report which showcases Children's leadership, innovation, andcommitment to Minnesota families with its breadth of research and sponsoredhealth services programs.
Advertisement
The report highlights the diversity and depth of Children's researchprograms, which will lead most immediately to advancements in clinical care.The report profiles seven different research studies and two sponsoredprograms dedicated to delivering the next generation of care for pediatricpatients.
"This is research that has a real impact on the improvement of day-to-daypediatric care. We are proud of the important and innovative research we do atChildren's," said Alan L. Goldbloom, MD, president and CEO of Children's. "Ourcommitment to research is a direct reflection of our organization's commitmentto the families that entrust their children to us each and every day."
New research highlighted in the report includes:
Cancer Studies
Children's of Minnesota, as a member of the Children's Oncology Group, isamong the top 10 hospitals for children with newly diagnosed cancer treatedannually.
Cardiovascular Studies
Children's pediatric cardiovascular program cares for nearly two-thirds ofpediatric patients hospitalized for cardiac surgery in the Twin Cities and haslong been a leader in creating better therapies for children with heartdisease.
Neonatology Studies
Children's has the largest high-risk neonatal referral program in theregion. Among its leading research projects:
Community Advocacy
Children's engages in active partnerships with communities, publicagencies, physicians and families to improve the quality and availability ofcare.
Currently, Children's has more than 300 ongoing research studies andprograms, which are coordinated by the Children's Center for Care Innovationand Research.
For more information on these programs, please visithttp://www.childrensmnpresskit.org/index.cfm.-- Children's is a founding member of a new international consortium, Therapeutic Advances in Childhood Leukemia (TACL), which focuses on rapidly developing and carrying out clinical trials for patients with recurrent leukemia. The 15-member consortium called upon pediatric oncologists from Children's to lead a clinical trial for a medication whose use in children is new. -- Fatigue is often a debilitating side effect for children and teens undergoing chemotherapy. Children's researchers are taking a look at how fatigue and physical performance change over time for cancer patients and what interventions might be able to increase energy levels for kids.
SOURCE Children's Hospitals and Clinics of Minnesota
